Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16M Buy
569,700
+19,329
+4% +$515K 0.44% 45
2025
Q4
$13.7M Buy
550,371
+40,920
+8% +$1.03M 0.35% 53
2025
Q3
$13M Buy
509,451
+89,822
+21% +$2.22M 0.33% 60
2025
Q2
$10.2M Buy
419,629
+54,578
+15% +$1.27M 0.29% 61
2025
Q1
$9.25M Buy
365,051
+73,670
+25% +$1.93M 0.31% 60
2024
Q4
$7.73M Buy
+291,381
New +$7.9M 0.24% 65

Other funds holding PFE

SBI Securities's PFE Position: Q1 2026 in Review

SBI Securities increased its Pfizer (PFE) stake by 3.5% in Q1 2026, buying an estimated $515K and bringing the position to 569,700 shares worth $16M. The position accounts for 0.44% of the portfolio, ranked #45.

SBI Securities first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SBI Securities held 569,700 shares of Pfizer worth $16M as of Q1 2026.
  • SBI Securities bought 19,329 Pfizer shares in Q1 2026, an estimated $515K.
  • Pfizer made up 0.44% of SBI Securities's portfolio in Q1 2026, its #45 holding.
  • SBI Securities first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.